Form 8-K - Current report:
SEC Accession No. 0001140361-24-044715
Filing Date
2024-10-31
Accepted
2024-10-31 08:50:00
Documents
19
Period of Report
2024-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20037830x2_8k.htm   iXBRL 8-K 35458
2 EXHIBIT 4.1 ny20037830x2_ex4-1.htm EX-4.1 101464
3 EXHIBIT 4.2 ny20037830x2_ex4-2.htm EX-4.2 92758
4 EXHIBIT 5.1 ny20037830x2_ex5-1.htm EX-5.1 13118
5 EXHIBIT 10.1 ny20037830x2_ex10-1.htm EX-10.1 186720
6 EXHIBIT 99.1 ny20037830x2_ex99-1.htm EX-99.1 11941
10 ny20037830x2_ex5-1img01.jpg GRAPHIC 34482
  Complete submission text file 0001140361-24-044715.txt   744512

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bngo-20241030.xsd EX-101.SCH 3886
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20241030_lab.xml EX-101.LAB 21966
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20241030_pre.xml EX-101.PRE 16058
22 EXTRACTED XBRL INSTANCE DOCUMENT ny20037830x2_8k_htm.xml XML 4234
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 241412634
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)